fda glp-1 enforcement news The New York Times spotlighted MEDVi. The had already warned the self-proclaimed 'fastest growing company in history.' Compound versions of GLP-1 drugs
Description
We estimated separately the incidence rate of DR for the GLP-1 RAs group and non-GLP-1 RAs group
Thats the key here
For oral semaglutide, check for changes in tablet appearance, unusual odors, or crumbling
Avoid temperature excursions, since warm temperatures degrade peptides regardless of dose
doi: 10.1016/b978-0-12-394440-5.00005-x
Contact your GP or optometrist promptly if you experience sudden vision changes, blurred vision, floaters, flashes of light, dark areas in your visual field, or distorted vision
